Kevin Krenitsky

May 11, 2016

Stemina Biomarker Discovery has appointed Kevin Krenitsky to its board of directors. Krenitsky recently joined Opgen as president. Previously, he served as chief commercial officer, senior vice president of international strategy, and chief operating officer of Foundation Medicine where he started working in June 2011.